Brightsurf Science News and Current Science News Events
 
Email a Friend Send to a friend
Printer Friendly Print Short-term use of antipsychotics in older adults with dementia linked to serious adverse events

Short-term use of antipsychotics in older adults with dementia linked to serious adverse events

May 27, 2008

Older adults with dementia who receive short-term courses of antipsychotic medications are more likely to be hospitalized or die than those who do not take the drugs, according to a report in the May 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

"Newer antipsychotic drugs (olanzapine, quetiapine fumarate and risperidone) have been on the market for more than a decade and are commonly used to treat the behavioral and psychological symptoms of dementia," the authors write as background information in the article. "Antipsychotic drugs are often used for short periods to treat agitation in clinical practice. They are frequently prescribed around the time of nursing home admission." About 17 percent of individuals admitted to nursing homes are starting on antipsychotic medication within 100 days, and 10 percent receive only a single prescription. Given the widespread use of short-term prescriptions, it is important to evaluate their safety, the authors note.




Paula A. Rochon, M.D., M.P.H., F.R.C.P.C., of the Institute for Clinical Evaluative Sciences (ICES), Ontario, and colleagues studied older adults with dementia living in the community or in nursing homes between 1997 and 2004. In each setting, the researchers identified three groups of equal size who were identical except for their exposure to antipsychotic medications. Among 20,682 older adults with dementia living in the community, 6,894 did not receive antipsychotics, 6,894 were prescribed atypical or newer antipsychotics and 6,894 were prescribed conventional antipsychotics, such as haloperidol or loxaprine. Among 20,559 older adults with dementia living in nursing homes, 6,853 received no antipsychotics, 6,853 received atypical antipsychotics and 6,853 received conventional antipsychotics.

Participants' medical records were examined for serious adverse events, defined as hospital admissions and death within 30 days of beginning therapy. "Relative to community-dwelling older adults with dementia who did not receive a prescription for antipsychotic drugs, similar older adults who did receive atypical antipsychotic drugs were three times more likely and those who received a conventional antipsychotic drug were almost four times more likely to experience a serious adverse event within 30 days of starting therapy," the authors write. "Relative to nursing home residents in the control group, individuals in the conventional antipsychotic therapy group were 2.4 times more likely to experience a serious adverse event leading to an acute care hospital admission or death. Those in the atypical antipsychotic group were 1.9 times more likely to experience a serious adverse event during 30 days of follow-up."

The analysis may underestimate the number of adverse events because of the short length of follow-up, the authors note. In addition, physicians who notice early signs of a problem may take patients off antipsychotics, avoiding more serious consequences, and many serious events experienced by nursing home residents are dealt with in the facility without hospital admission. "Our results exploring serious adverse events likely identify only the 'tip of the iceberg'," they write. "Antipsychotic drugs should be prescribed with caution even for short-term therapy."

JAMA and Archives Journals



Related Antipsychotic News Articles Antipsychotic News and Current Antipsychotic Events RSS Antipsychotic News and Current Antipsychotic Events RSS
Risks and benefits of antipsychotics in children and adolescents
Many of the psychiatric disorders observed in adults have their onset in childhood or adolescence. In fact some studies show that at least 20% of children and adolescents will fulfil a diagnostic criterion for a mental disorder before reaching adulthood.

Anti-psychotic drug use in the elderly increases despite drug safety warnings
Three regulatory warnings of serious adverse events slowed the growth of use of atypical antipsychotic drugs among elderly patients with dementia, but they did not reduce the overall prescription rate of these drugs.

Looking beyond the drug receptor for clues to drug effectiveness
Antipsychotic drugs that are widely used to treat schizophrenia and other problems may not work as scientists have assumed, according to findings from Duke University Medical Center researchers that could lead to changes in how these drugs are developed and prescribed.

Estrogen relieves psychotic symptoms in women with schizophrenia
When combined with antipsychotic medications, the estrogen estradiol appears to be a useful treatment in women with schizophrenia, according to a report in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

Violence declines with medication use in some with schizophrenia
Some schizophrenia patients become less prone to violence when taking medication, but those with a history of childhood conduct problems continue to pose a higher risk even with treatment, according to a new study by researchers at Duke University Medical Center.

Hopkins researchers discover new link to schizophrenia
Neuroscientists at Johns Hopkins have discovered that mice lacking an enzyme that contributes to Alzheimer disease exhibit a number of schizophrenia-like behaviors.

Lack of motivation in schizophrenia linked to brain chemical imbalance
A study of patients with psychotic illnesses such as schizophrenia suggests an alternative explanation for why many sufferers lack motivation. The research is described today BioMed Central's journal BMC Psychiatry.

First do no harm? UH prof taking opposite approach to treat asthma
One month of tough breathing may help asthma sufferers breathe easier in the long run, according to research from one University of Houston professor.

Treatment With An Antipsychotic Drug Found To Cause Changes In Metabolism Earlier Than Expected
Schizophrenia is a complex type of psychotic mental illness characterized by thoughts that are uncoupled from reality.

Stanford researcher criticizes FDA plans to reduce oversight of off-label drug use
Proposed guidelines from the U.S. Food and Drug Administration would allow companies to market more drugs for unapproved uses and are a step in the wrong direction, said a researcher from the Stanford University School of Medicine.
More Antipsychotic News Articles


Essential Psychopharmacology: the Prescriber's Guide: Antipsychotics and Mood Stabilizers (Essential Psychopharmacology Series)
by Stephen M. Stahl

In response to the rapid developments in pscyhopharmacology, this is a spin-off from Stephen Stahl's new completely revised and updated edition of his much acclaimed Prescriber's Guide. It covers the 20 most important drugs in use today for psychosis and mood stabilization. From a review of the first Prescriber's Guide: ' ... The clinical tips and pearls that are found in each entry are...



Medicines for Mental Health: The Ultimate Guide to Psychiatric Medication
by Kevin PhD Thompson

A finalist in the National Indie Excellence 2008 book awards, this book was written for anyone who suffers from sexual dysfunction, depression, bipolar disorder, or schizophrenia (or cares for someone who does). Medicines for Mental Health is the first book to provide detailed and readable information about all psychiatric medications, and other medical treatments, for these mental illnesses....



Antipsychotics and Mood Stabilizers: Stahl's Essential Psychopharmacology, 3rd edition (Essential Psychopharmacology Series)
by Stephen M. Stahl

Relying upon the best-selling third edition of Stahl's Essential Psychopharmacology, Dr. Stephen M. Stahl has revised chapters covering antipsychotics and mood stabilizers for this third edition of Antipsychotics and Mood Stabilizers. More than one-third longer than the previous edition, Antipsychotics and Mood Stabilizers is essential reading for professionals treating psychosis and students...



America Fooled: The Truth About Antidepressants, Antipsychotics And How We've Been Deceived
by Timothy Scott

America Fooled is the non-sensational, fact-filled story of how Americans have come to believe that depression and other mental problems are caused by chemical imbalances which can be fixed with pills. It reveals how the drug studies used to achieve FDA approval are designed, paid for and written by the drug companies themselves and are purposely deceptive. Part 1 of America Fooled is focused on...



The Depression Advantage
by Tom Wootton

In The Depression Advantage, Tom Wootton reveals his insight about the surprising advantages of the depressive state, with the view that people with mental conditions can lead extraordinary lives. Tom has developed an entirely new system of representing the broad spectrum of emotional states experienced by people with mental conditions. His revolutionary ideas about redefining functionality...



Essential Psychopharmacology of Antipsychotics and Mood Stabilizers (Essential Psychopharmacology Series)
by Stephen M. Stahl

Drawn from the best-selling second edition of Essential Psychopharmacology, Steve Stahl has revised and updated the chapters covering antipsychotics and mood stabilizers in this separate volume. This new book covers the many dimensions of psychosis, particularly as associated with schizophrenia, and examines the role of dopamine in psychosis along with the various theories about the causes,...



Responding to Psychological Emergencies: A Field Guide
by Jeffrey A. Thomas, S. Joseph Woodall

Field Guide for Psychological Emergencies is a quick reference source for rapid intervention and mitigation of psychologically-based field emergencies. The guide provides a user-friendly, cross-referenced, pragmatic reference guide to a variety of psychological maladies that are encountered by emergency services personnel and a variety of other public service professionals. The field guide can...



The Essential Guide to Psychiatric Drugs: Includes The Most Recent Information On: Antidepressants, Tranquilizers and Antianxiety Drugs, Antipsychotics, ... More (Essential Guide to Psychiatric Drugs)
by Jack M. Gorman

Informative, accessible, and easy to use, The Essential Guide to Psychiatric Drugs has become a classic and indispensable resource for the layperson and professional alike. With detailed descriptions of all the psychiatric medications available today, including their uses, side-effects, cost, dosage, and more, consumers can take an active role in their mental health and know what to expect from...



Psychopharmacology of Antipsychotics
by Stephen M. Stahl



Neuroleptic Malignant Syndrome and Related Conditions
by Stanley N., M.D. Caroff, Paul E., Jr., M.D. Keck, Arthur Lazarus

Neuroleptic malignant syndrome (NMS) and other hyperthermic conditions are rare complications of antipsychotic drugs that can cause discomfort, disability, and even death. As a result, every psychiatrist, physician, and mental health care professional needs to understand and identify these disorders in time to prevent a fatal outcome. Neuroleptic Malignant Syndrome and Related Conditions is an...

© 2008 BrightSurf.com